These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15113380)

  • 1. Implementation of a strategy to prevent TRALI in a regional blood centre.
    Insunza A; Romon I; Gonzalez-Ponte ML; Hoyos A; Pastor JM; Iriondo A; Hermosa V
    Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
    Keller-Stanislawski B; Reil A; Günay S; Funk MB
    Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
    Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
    Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
    Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
    Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
    Sachs UJ; Kauschat D; Bein G
    Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
    Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M
    Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation.
    Nicolle AL; Chapman CE; Carter V; Wallis JP
    Transfus Med; 2004 Jun; 14(3):225-30. PubMed ID: 15180814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
    Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
    Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-related acute lung injury: current concepts for the clinician.
    Triulzi DJ
    Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
    Curtis BR; McFarland JG
    Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucocyte antibodies in blood donors and a look back on recipients of their blood components.
    Maślanka K; Michur H; Zupańska B; Uhrynowska M; Nowak J
    Vox Sang; 2007 Apr; 92(3):247-9. PubMed ID: 17348874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
    Reil A; Keller-Stanislawski B; Günay S; Bux J
    Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood donor and component management strategies to prevent transfusion-related acute lung injury (TRALI).
    Mair DC; Hirschler N; Eastlund T
    Crit Care Med; 2006 May; 34(5 Suppl):S137-43. PubMed ID: 16617258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-related acute lung injury reports in the Netherlands: an observational study.
    van Stein D; Beckers EA; Sintnicolaas K; Porcelijn L; Danovic F; Wollersheim JA; Brand A; van Rhenen DJ
    Transfusion; 2010 Jan; 50(1):213-20. PubMed ID: 19694998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
    Kleinman S; Grossman B; Kopko P
    Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion.
    Bux J
    Vox Sang; 2005 Jul; 89(1):1-10. PubMed ID: 15938734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report.
    Lydaki E; Bolonaki E; Nikoloudi E; Chalkiadakis E; Iniotaki-Theodoraki A
    Transfus Apher Sci; 2005 Oct; 33(2):107-11. PubMed ID: 16115801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
    Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
    Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.